Skip to main content
Clinical Trials/NCT06715761
NCT06715761
Recruiting
Not Applicable

Effectiveness of Manual and Instrumental Myofascial Release in Chronic Low Back Pain and the Posture of Practitioners CrossFit®: Protocol of a Randomized Controlled Clinical

Gabriela Souza de Vasconcelos1 site in 1 country51 target enrollmentNovember 1, 2024
ConditionsLow Back Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
Gabriela Souza de Vasconcelos
Enrollment
51
Locations
1
Primary Endpoint
Pain intensity
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Background: Chronic low back pain (LBP) can lead to major functional disabilities and force people to take time off work, sports or leisure activities. Regular physical exercise is an important ally in reducing the risk factors for most diseases, and CrossFit® is one of the modalities that has been gaining momentum when choosing an exercise. However, the intensity recommended in training can collaborate with the development of musculoskeletal problems such as pain and postural changes, interfering with the development of the practice, with low back pain being one of the most common disorders in these practitioners, especially caused by mechanical stress. Considering that CrossFit® practitioners have already incorporated physical exercise into their routine, passive techniques such as myofascial release (ML) have been discussed as a form of treatment for LBP. For this reason, this study was designed to verify the efficacy of ML in the LBP of CrossFit® practitioners, comprising two techniques, one manual and one instrumental, and to see if the outcome of the LBP alters the posture of the spine.

This is a randomised controlled clinical that will be conducted in a CrossFit® box in the city of Goiânia-GO, Brazil. At least 51 people will take part who have been doing CrossFit® for at least 3 months, who have LBP, are aged between 18-59 and are not undergoing any other treatment for low back pain. There will be two experimental groups, one that will receive manual MR and the other, cupping therapy, as well as a control group that will not receive any technique. The sessions will take place twice a week for 8 weeks. The primary outcome will be low back pain intensity, assessed at baseline, weekly and after 8 weeks, and the secondary outcomes, which will be postural deviations, spinal mobility and history of musculoskeletal pain, assessed at baseline and at the end of 8 weeks. There will be no blinding between therapist and participants.

Discussion: This study will investigate whether MR is effective in relation to LBP, given that some results have already shown positive responses in acute conditions, while also verifying the repercussions on the postural aspect. The results could provide additional knowledge about the best technique to use and, having applicability to our outcomes, will favour and simplify treatment, helping professionals to make clinical decisions.

Registry
clinicaltrials.gov
Start Date
November 1, 2024
End Date
July 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Gabriela Souza de Vasconcelos
Responsible Party
Sponsor Investigator
Principal Investigator

Gabriela Souza de Vasconcelos

Professor

Universidade Federal de Goias

Eligibility Criteria

Inclusion Criteria

  • men and women aged between 18 and 59 years;
  • presence of low back pain for at least 12 weeks;
  • have started regular CrossFit® activity at least 3 months ago.

Exclusion Criteria

  • perform other physical activity than CrossFit®;
  • continuous use of painkillers;
  • previous pathologies or spinal surgery;
  • amputations;
  • haematological disorders;
  • fibromyalgia;
  • hypersensitivity or skin lesions.

Outcomes

Primary Outcomes

Pain intensity

Time Frame: Baseline, once a week throughout the intervention period (at the beginning of each week) and post intervention (8 weeks)

Pain intensity, related to chronic low back pain, will be measured using the Visual Analogue Scale (VAS), where 0 represents "no pain" and 10 represents "the worst pain possible". Participants will indicate their usual pain.

Secondary Outcomes

  • Spinal postural deviations(Baseline and post intervention (8 weeks))
  • Spine mobility(Baseline and post intervention (8 weeks))
  • History of musculoskeletal pain(Baseline and post intervention (8 weeks))

Study Sites (1)

Loading locations...

Similar Trials